Financial News
Articles published by BWX Technologies, Inc.


Via Business Wire
Tickers
BWXT

BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
September 13, 2022
Via Business Wire
Tickers
BWXT

BWXT Names Robert Duffy as Chief Administrative Officer
August 22, 2022
Via Business Wire
Tickers
BWXT


Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT

BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
June 27, 2022
Via Business Wire
Tickers
BWXT

BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
June 13, 2022
Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT


Via Business Wire
Tickers
BWXT



BWXT Awarded $1 Billion in Naval Nuclear Propulsion Program Options
February 23, 2022
Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT

BWX Technologies Reports Fourth Quarter and Full-Year 2021 Results
February 22, 2022
Via Business Wire
Tickers
BWXT

BWX Technologies to Announce Fourth Quarter and Full-Year 2021 Results on Tuesday, February 22
January 31, 2022
Via Business Wire
Tickers
BWXT


BWXT Names Robb A. LeMasters as Next Chief Financial Officer
November 05, 2021
Via Business Wire
Tickers
BWXT


BWXT Awarded $21 Billion Environmental Management Contract for DOE’s Savannah River Site
October 28, 2021
Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT

BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
September 16, 2021
Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT

BWX Technologies Reports Second Quarter 2021 Results and Continues Progress On Future Growth Milestones
August 02, 2021
Via Business Wire
Tickers
BWXT

Via Business Wire
Tickers
BWXT


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.